文献速递胃肠外科围术期管理与 ERAS

磁括约肌增强术在袖状胃切除与Roux-en-Y胃旁路术后患者的长期结局分析

Long-term outcomes of magnetic sphincter augmentation in sleeve gastrectomy and Roux-en-Y gastric bypass patients: a comprehensive analysis.
PubMed 文献 · Surg Endosc · 2024-07-19

本研究回顾性分析了16例减重术后接受磁括约肌增强术(MSA)患者的长期结局,其中袖状胃切除14例、胃旁路2例,平均随访48个月。结果显示每日PPI使用率从88%降至25%以下,GERD-HRQL评分从基线50.6降至正常范围,反流症状完全缓解,无不良事件。MSA是经选择的减重术后反流患者安全、有效且持久的管理工具。

要点

  • 减重术后MSA患者长期GERD-HRQL评分恢复正常,PPI使用率显著下降。
  • 反流症状完全缓解,仅2例出现吞咽困难、2例持续反流。
  • MSA在经选择的减重术后患者中安全有效且持久。

核心结论

  • MSA在经选择的减重术后患者中可长期改善GERD-HRQL评分并缓解反流症状,减少PPI使用,安全有效且持久。

主要发现

  • 每日PPI使用率从88%降至大于三年时的25%。
  • GERD-HRQL评分从基线50.6(范围27-70)在长期随访时恢复正常。
  • 反流症状完全缓解;长期随访中2例出现吞咽困难,2例持续反流,无不良事件。
  • 术前13/13例Bravo pH研究阳性,16例LES压力低于18 mmHg,8例活检证实食管炎。

临床怎么用

  • 对于减重术后经选择的顽固性反流患者,MSA可作为安全有效的长期管理选项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Management of gastroesophageal reflux disease after bariatric procedures can be challenging. There are very few long-term studies in this arena. This study aims to evaluate the long-term outcomes of the magnetic sphincter augmentation (MSA) reflux management system in a cohort of bariatric patients who had previously undergone sleeve gastrectomy and Roux-en-Y gastric bypass, with a focus on assessing gastroesophageal reflux disease (GERD) scores, medication use, and patient-reported symptoms. METHODS: We conducted a retrospective chart review of 16 consecutive bariatric patients who received MSA implants following sleeve gastrectomy (n = 14) or gastric bypass (n = 2) surgeries. Data were collected regarding BMI, GERD quality of life assessments (GERD-HRQL), reflux symptoms, and use of PPIs in the sleeve/RGB patients through an extended period with a mean follow-up of 48 months. RESULTS: Patients were followed up for a range of .5-84 months. Preoperative assessments included upper gastrointestinal imaging (UGI), high-resolution manometry, Bravo pH studies, and esophagogastroduodenoscopy (EGD). Three patients exhibited reflux on UGI, and 13/13 patients had positive Bravo studies preoperatively. Sixteen patients had a lower esophageal sphincter (LES) pressure under 18 mmHg, and eight patients had biopsy-proven esophagitis. Long-term outcomes are as follows. Daily PPI use fell from 88 to 25% at greater than three years. GERD-HRQL scores fell from 50.6 at baseline (range 27-70) and normalized at long-term follow-up. GERD symptom of regurgitation completely resolved. At long term, two patients had dysphagia and two patients had ongoing reflux. No adverse events were noted. CONCLUSION: This is the first long-term outcomes study of magnetic sphincter augmentation placement after bariatric surgery. Our study showed the majority of patients had long-term improvement in GERD-HRQL scores and resolution/ relief of their reflux symptoms, with decreased use of PPIs. MSA is a safe, effective and durable management tool for reflux after bariatric surgery in carefully selected patients.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Ibrahim MA, Mowoh DP, Al Khadem M, et al. Long-term outcomes of magnetic sphincter augmentation in sleeve gastrectomy and Roux-en-Y gastric bypass patients: a comprehensive analysis. Surg Endosc. 2024. PMID: 39030413. doi:10.1007/s00464-024-11059-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。